 | • レポートコード：QYR2104Z2230 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、エピゲノムのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（試薬、キット、器具、酵素、サービス）、用途別市場規模（腫瘍、非腫瘍）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・エピゲノムの市場動向 ・企業の競争状況、市場シェア ・エピゲノムの種類別市場規模（試薬、キット、器具、酵素、サービス） ・エピゲノムの用途別市場規模（腫瘍、非腫瘍） ・エピゲノムの北米市場規模2016-2027（アメリカ、カナダ） ・エピゲノムのヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・エピゲノムのアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・エピゲノムの中南米市場規模2016-2027（メキシコ、ブラジル） ・エピゲノムの中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche Diagnostics、Thermo Fisher Scientific、Eisai、Novartis） ・結論 |
Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell.
Market Analysis and Insights: Global Epigenomic Market
The global Epigenomic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Epigenomic market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Epigenomic market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Epigenomic market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Epigenomic market.
Global Epigenomic Scope and Market Size
Epigenomic market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Epigenomic market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Reagents
Kits
Instruments
Enzymes
Services
Segment by Application
Oncology
Non Oncology
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche Diagnostics
Thermo Fisher Scientific
Eisai
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenomic Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Reagents
1.2.3 Kits
1.2.4 Instruments
1.2.5 Enzymes
1.2.6 Services
1.3 Market by Application
1.3.1 Global Epigenomic Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Oncology
1.3.3 Non Oncology
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Epigenomic Market Perspective (2016-2027)
2.2 Epigenomic Growth Trends by Regions
2.2.1 Epigenomic Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Epigenomic Historic Market Share by Regions (2016-2021)
2.2.3 Epigenomic Forecasted Market Size by Regions (2022-2027)
2.3 Epigenomic Industry Dynamic
2.3.1 Epigenomic Market Trends
2.3.2 Epigenomic Market Drivers
2.3.3 Epigenomic Market Challenges
2.3.4 Epigenomic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Epigenomic Players by Revenue
3.1.1 Global Top Epigenomic Players by Revenue (2016-2021)
3.1.2 Global Epigenomic Revenue Market Share by Players (2016-2021)
3.2 Global Epigenomic Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Epigenomic Revenue
3.4 Global Epigenomic Market Concentration Ratio
3.4.1 Global Epigenomic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epigenomic Revenue in 2020
3.5 Epigenomic Key Players Head office and Area Served
3.6 Key Players Epigenomic Product Solution and Service
3.7 Date of Enter into Epigenomic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Epigenomic Breakdown Data by Type
4.1 Global Epigenomic Historic Market Size by Type (2016-2021)
4.2 Global Epigenomic Forecasted Market Size by Type (2022-2027)
5 Epigenomic Breakdown Data by Application
5.1 Global Epigenomic Historic Market Size by Application (2016-2021)
5.2 Global Epigenomic Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Epigenomic Market Size (2016-2027)
6.2 North America Epigenomic Market Size by Type
6.2.1 North America Epigenomic Market Size by Type (2016-2021)
6.2.2 North America Epigenomic Market Size by Type (2022-2027)
6.2.3 North America Epigenomic Market Size by Type (2016-2027)
6.3 North America Epigenomic Market Size by Application
6.3.1 North America Epigenomic Market Size by Application (2016-2021)
6.3.2 North America Epigenomic Market Size by Application (2022-2027)
6.3.3 North America Epigenomic Market Size by Application (2016-2027)
6.4 North America Epigenomic Market Size by Country
6.4.1 North America Epigenomic Market Size by Country (2016-2021)
6.4.2 North America Epigenomic Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Epigenomic Market Size (2016-2027)
7.2 Europe Epigenomic Market Size by Type
7.2.1 Europe Epigenomic Market Size by Type (2016-2021)
7.2.2 Europe Epigenomic Market Size by Type (2022-2027)
7.2.3 Europe Epigenomic Market Size by Type (2016-2027)
7.3 Europe Epigenomic Market Size by Application
7.3.1 Europe Epigenomic Market Size by Application (2016-2021)
7.3.2 Europe Epigenomic Market Size by Application (2022-2027)
7.3.3 Europe Epigenomic Market Size by Application (2016-2027)
7.4 Europe Epigenomic Market Size by Country
7.4.1 Europe Epigenomic Market Size by Country (2016-2021)
7.4.2 Europe Epigenomic Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Epigenomic Market Size (2016-2027)
8.2 Asia-Pacific Epigenomic Market Size by Type
8.2.1 Asia-Pacific Epigenomic Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Epigenomic Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Epigenomic Market Size by Type (2016-2027)
8.3 Asia-Pacific Epigenomic Market Size by Application
8.3.1 Asia-Pacific Epigenomic Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Epigenomic Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Epigenomic Market Size by Application (2016-2027)
8.4 Asia-Pacific Epigenomic Market Size by Region
8.4.1 Asia-Pacific Epigenomic Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Epigenomic Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Epigenomic Market Size (2016-2027)
9.2 Latin America Epigenomic Market Size by Type
9.2.1 Latin America Epigenomic Market Size by Type (2016-2021)
9.2.2 Latin America Epigenomic Market Size by Type (2022-2027)
9.2.3 Latin America Epigenomic Market Size by Type (2016-2027)
9.3 Latin America Epigenomic Market Size by Application
9.3.1 Latin America Epigenomic Market Size by Application (2016-2021)
9.3.2 Latin America Epigenomic Market Size by Application (2022-2027)
9.3.3 Latin America Epigenomic Market Size by Application (2016-2027)
9.4 Latin America Epigenomic Market Size by Country
9.4.1 Latin America Epigenomic Market Size by Country (2016-2021)
9.4.2 Latin America Epigenomic Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Epigenomic Market Size (2016-2027)
10.2 Middle East & Africa Epigenomic Market Size by Type
10.2.1 Middle East & Africa Epigenomic Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Epigenomic Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Epigenomic Market Size by Type (2016-2027)
10.3 Middle East & Africa Epigenomic Market Size by Application
10.3.1 Middle East & Africa Epigenomic Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Epigenomic Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Epigenomic Market Size by Application (2016-2027)
10.4 Middle East & Africa Epigenomic Market Size by Country
10.4.1 Middle East & Africa Epigenomic Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Epigenomic Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche Diagnostics
11.1.1 Roche Diagnostics Company Details
11.1.2 Roche Diagnostics Business Overview
11.1.3 Roche Diagnostics Epigenomic Introduction
11.1.4 Roche Diagnostics Revenue in Epigenomic Business (2016-2021)
11.1.5 Roche Diagnostics Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Epigenomic Introduction
11.2.4 Thermo Fisher Scientific Revenue in Epigenomic Business (2016-2021)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Eisai
11.3.1 Eisai Company Details
11.3.2 Eisai Business Overview
11.3.3 Eisai Epigenomic Introduction
11.3.4 Eisai Revenue in Epigenomic Business (2016-2021)
11.3.5 Eisai Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Epigenomic Introduction
11.4.4 Novartis Revenue in Epigenomic Business (2016-2021)
11.4.5 Novartis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Epigenomic Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Reagents
Table 3. Key Players of Kits
Table 4. Key Players of Instruments
Table 5. Key Players of Enzymes
Table 6. Key Players of Services
Table 7. Global Epigenomic Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Epigenomic Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Epigenomic Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Epigenomic Market Share by Regions (2016-2021)
Table 11. Global Epigenomic Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Epigenomic Market Share by Regions (2022-2027)
Table 13. Epigenomic Market Trends
Table 14. Epigenomic Market Drivers
Table 15. Epigenomic Market Challenges
Table 16. Epigenomic Market Restraints
Table 17. Global Epigenomic Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Epigenomic Market Share by Players (2016-2021)
Table 19. Global Top Epigenomic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenomic as of 2020)
Table 20. Ranking of Global Top Epigenomic Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Epigenomic Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Epigenomic Product Solution and Service
Table 24. Date of Enter into Epigenomic Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Epigenomic Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Epigenomic Revenue Market Share by Type (2016-2021)
Table 28. Global Epigenomic Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Epigenomic Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Epigenomic Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Epigenomic Revenue Market Share by Application (2016-2021)
Table 32. Global Epigenomic Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Epigenomic Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Epigenomic Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Epigenomic Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Epigenomic Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Epigenomic Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Epigenomic Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Epigenomic Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Epigenomic Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Epigenomic Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Epigenomic Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Epigenomic Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Epigenomic Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Epigenomic Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Epigenomic Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Epigenomic Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Epigenomic Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Epigenomic Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Epigenomic Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Epigenomic Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Epigenomic Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Epigenomic Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Epigenomic Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Epigenomic Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Epigenomic Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Epigenomic Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Epigenomic Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Epigenomic Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Epigenomic Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Epigenomic Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Epigenomic Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Epigenomic Market Size by Country (2022-2027) & (US$ Million)
Table 64. Roche Diagnostics Company Details
Table 65. Roche Diagnostics Business Overview
Table 66. Roche Diagnostics Epigenomic Product
Table 67. Roche Diagnostics Revenue in Epigenomic Business (2016-2021) & (US$ Million)
Table 68. Roche Diagnostics Recent Development
Table 69. Thermo Fisher Scientific Company Details
Table 70. Thermo Fisher Scientific Business Overview
Table 71. Thermo Fisher Scientific Epigenomic Product
Table 72. Thermo Fisher Scientific Revenue in Epigenomic Business (2016-2021) & (US$ Million)
Table 73. Thermo Fisher Scientific Recent Development
Table 74. Eisai Company Details
Table 75. Eisai Business Overview
Table 76. Eisai Epigenomic Product
Table 77. Eisai Revenue in Epigenomic Business (2016-2021) & (US$ Million)
Table 78. Eisai Recent Development
Table 79. Novartis Company Details
Table 80. Novartis Business Overview
Table 81. Novartis Epigenomic Product
Table 82. Novartis Revenue in Epigenomic Business (2016-2021) & (US$ Million)
Table 83. Novartis Recent Development
Table 84. Research Programs/Design for This Report
Table 85. Key Data Information from Secondary Sources
Table 86. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epigenomic Market Share by Type: 2020 VS 2027
Figure 2. Reagents Features
Figure 3. Kits Features
Figure 4. Instruments Features
Figure 5. Enzymes Features
Figure 6. Services Features
Figure 7. Global Epigenomic Market Share by Application: 2020 VS 2027
Figure 8. Oncology Case Studies
Figure 9. Non Oncology Case Studies
Figure 10. Epigenomic Report Years Considered
Figure 11. Global Epigenomic Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Epigenomic Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Epigenomic Market Share by Regions: 2020 VS 2027
Figure 14. Global Epigenomic Market Share by Regions (2022-2027)
Figure 15. Global Epigenomic Market Share by Players in 2020
Figure 16. Global Top Epigenomic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epigenomic as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Epigenomic Revenue in 2020
Figure 18. Global Epigenomic Revenue Market Share by Type (2016-2021)
Figure 19. Global Epigenomic Revenue Market Share by Type (2022-2027)
Figure 20. North America Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Epigenomic Market Share by Type (2016-2027)
Figure 22. North America Epigenomic Market Share by Application (2016-2027)
Figure 23. North America Epigenomic Market Share by Country (2016-2027)
Figure 24. United States Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Epigenomic Market Share by Type (2016-2027)
Figure 28. Europe Epigenomic Market Share by Application (2016-2027)
Figure 29. Europe Epigenomic Market Share by Country (2016-2027)
Figure 30. Germany Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Epigenomic Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Epigenomic Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Epigenomic Market Share by Region (2016-2027)
Figure 40. China Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Epigenomic Market Share by Type (2016-2027)
Figure 48. Latin America Epigenomic Market Share by Application (2016-2027)
Figure 49. Latin America Epigenomic Market Share by Country (2016-2027)
Figure 50. Mexico Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Epigenomic Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Epigenomic Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Epigenomic Market Share by Country (2016-2027)
Figure 56. Turkey Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Epigenomic Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Roche Diagnostics Revenue Growth Rate in Epigenomic Business (2016-2021)
Figure 60. Thermo Fisher Scientific Revenue Growth Rate in Epigenomic Business (2016-2021)
Figure 61. Eisai Revenue Growth Rate in Epigenomic Business (2016-2021)
Figure 62. Novartis Revenue Growth Rate in Epigenomic Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の分子生物学用酵素・キット・試薬市場規模・現状・予測（2021年-2027年） There is a rise in the prevalence of genetic disorders since the recent past, which in turn has driven adoption of molecular diagnostics. Key processes of molecular diagnostics such as epigenetics and polymerase chain reaction (PCR) require molecular biology enzymes, kits & reagents. With mounting i…- 世界のゲノミクス・プロテオミクス試薬・研究キット・分析機器市場規模・現状・予測（2021年-2027年） The market is segmented into two major areas, namely, the genomics and proteomics reagent kits market and the genomics and proteomics analytical tools market. The reagent and research kits segment deals with the products used in sample preparation, purification and isolation, electrophoresis, lab-on…
- 世界の分子生物学用酵素・キット・試薬市場 2021：企業別、地域別、種類・用途別 The Molecular Biology Enzymes And Kits & Reagents market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- 世界の腫瘍学ベース分子診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Oncology Based Molecular Diagnostic Market The global Oncology Based Molecular Diagnostic market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and hig…
- 世界の腫瘍栄養市場規模・現状・予測（2021年-2027年） Cancers are among the leading causes of morbidity and mortality worldwide, and the number of new cases is expected to rise significantly over the next decades. Nutritional oncology is an increasingly active interdisciplinary field where cancer is investigated as both a systemic and local disease ori…